⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL432068 | 0.94 | — | — | |
| SCHEMBL7370700 | 0.89 | — | — | |
| Potassium SCHEMBL3850422 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL27258623 | 0.89 | — | — | |
| SCHEMBL2102318 | 0.67 | — | — | |
| Lithium SCHEMBL30184823 | 0.67 | — | — | |
| SCHEMBL2103904 | 0.63 | — | — | |
| Dimethylamine SCHEMBL668291 | 0.63 | — | — | |
| SCHEMBL21851767 | 0.60 | — | — | |
| Lithium SCHEMBL30924522 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1841747-B1 | OXAZOLE HYDROXAMIC ACID DERIVATIVES AND USE THEREOF | SK BIOPHARMACEUTICALS CO LTD (KR) | 2012-09-05 | — | — | EP | claimed |
| US-20090209596-A1 | Oxazole Hydroxamic Acid Derivatives and Use Thereof | SK HOLDINGS CO., LTD | 2009-08-20 | — | — | US | claimed |
| EP-1841747-A1 | OXAZOLE HYDROXAMIC ACID DERIVATIVES AND USE THEREOF | SK Corporation (KR) | 2007-10-10 | — | — | EP | claimed |
| WO-2006075888-A1 | OXAZOLE HYDROXAMIC ACID DERIVATIVES AND USE THEREOF | SK CORPORATION (KR) | 2006-07-20 | — | — | WO | claimed |
| US-11131926-B2 | Resist composition and resist patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-09-28 | — | — | US | disclosed |
| US-10754248-B2 | Sulfonium salt, resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-08-25 | — | — | US | disclosed |
| US-20190010119-A1 | RESIST COMPOSITION AND RESIST PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-01-10 | — | — | US | disclosed |
| US-20180275516-A1 | SULFONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-09-27 | — | — | US | disclosed |
| US-9991560-B2 | Liquid electrolyte for fluoride ion battery and fluoride ion battery | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2018-06-05 | — | — | US | disclosed |
| US-9954250-B2 | — | — | 2018-04-24 | — | — | US | disclosed |
| US-20160087308-A1 | LIQUID ELECTROLYTE FOR FLUORIDE ION BATTERY AND FLUORIDE ION BATTERY | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2016-03-24 | — | — | US | disclosed |
| EP-2999044-A1 | LIQUID ELECTROLYTE FOR FLUORIDE ION BATTERY AND FLUORIDE ION BATTERY | Toyota Jidosha Kabushiki Kaisha (JP) | 2016-03-23 | — | — | EP | disclosed |
| EP-0838453-A1 | HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 1998-04-29 | — | — | EP | disclosed |
| WO-1998016524-A1 | HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS | COR THERAPEUTICS, INC. (US) | 1998-04-23 | — | — | WO | disclosed |
| EP-0783507-A1 | COMPOUNDS USEFUL AS ANTIPROLIFERATIVE AGENTS AND GARFT INHIBITORS | AGOURON PHARMACEUTICALS, INC. (US) | 1997-07-16 | — | — | EP | disclosed |
| EP-0758240-A1 | PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 1997-02-19 | — | — | EP | disclosed |
| WO-1996003407-A1 | COMPOUNDS USEFUL AS ANTIPROLIFERATIVE AGENTS AND GARFT INHIBITORS | AGOURON PHARMACEUTICALS, INC. (US) | 1996-02-08 | — | — | WO | disclosed |
| WO-1995028935-A1 | PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 1995-11-02 | — | — | WO | disclosed |
| EP-0296225-A1 | CARBAMOYLOXYLABDANES | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1988-12-28 | — | — | EP | disclosed |
| WO-1988005047-A1 | CARBAMOYLOXYLABDANES | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1988-07-14 | — | — | WO | disclosed |